5 authorised products containing Alirocumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Praluent 150 mg solution for injection in pre-filled pen EU/1/15/1031/007-009 |
Alirocumab | Sanofi-Aventis Groupe | — |
| Praluent 150 mg solution for injection in pre-filled syringe EU/1/15/1031/010-012 |
Alirocumab | Sanofi-Aventis Groupe | — |
| Praluent 300 mg solution for injection in pre-filled pen EU/1/15/1031/019-020 |
Alirocumab | Sanofi-Aventis Groupe | — |
| Praluent 75 mg solution for injection in pre-filled pen EU/1/15/1031/001-003 |
Alirocumab | Sanofi-Aventis Groupe | — |
| Praluent 75 mg solution for injection in pre-filled syringe EU/1/15/1031/004-006 |
Alirocumab | Sanofi-Aventis Groupe | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.